HIGHLIGHTS
- who: SYNOPSIS, and Release, date from the Mucormycosis Outbreak, India have published the paper: Multicenter Case-Control Study of COVID-19-Associated Mucormycosis Outbreak, India, in the Journal: (JOURNAL) of December/19,/2022
- what: The aim of the study was to assess whether treatment practices in COVID-19 were associated with the occurrence of CAM. The authors provide strong evidence to incriminate glucocorticoid therapy in CAM even after adjusting for p value 0.0001 0.99 0.13 0.04 0.42 0.08 0.12 0.0001 0.13 0.001 0.0001 host . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.